- $6.73bn
- $7.57bn
- $1.48bn
Avadel shares jump as Alkermes raises buyout bid
Alkermes raises offer for Avadel after Lundbeck bid (updated)
Alkermes raises offer for Avadel after Lundbeck bid
Brief: Avadel Board Of Directors Declares Lundbeck Proposal A “Company Superior Proposal”
Nasdaq biotech index hits record high, set to gain nearly 5% this week
Advel jumps after Lundbeck's unsolicited bid
Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel (updated)
Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel
Brief: Avadel Receives Unsolicited Proposal From Lundbeck
U.S. STOCKS ON THE MOVE-TransDigm, Citigroup, Cisco Systems
U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
Alkermes rises after narcolepsy drug meets main goal in mid-stage trial
Alkermes' narcolepsy drug shows promise in mid-stage trial (updated)
Brief: Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
Alkermes' narcolepsy drug meets main goal in a mid-stage trial
U.S. STOCKS ON THE MOVE-Microsoft, Smithfield Foods, SoFi Technologies
U.S. STOCKS ON THE MOVE-PayPal, Microsoft, SoFi
U.S. STOCKS ON THE MOVE- PayPal, SoFi Technologies, JetBlue Airways